Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03246529
Title A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM (GENESIS)
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors BioLineRx, Ltd.
Indications

multiple myeloma

Therapies

Filgrastim

BKT140 + Filgrastim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.